An efficient synthesis of enantiopure (R)-heteroarylpyrimidine analogs.

about

An efficient synthesis of enantiopure (R)-heteroarylpyrimidine analogs.

Item

http://www.wikidata.org/entity/Q43692897

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

An efficient synthesis of enantiopure (R)-heteroarylpyrimidine analogs.

@en

An efficient synthesis of enantiopure

@nl

type

Item

label

An efficient synthesis of enantiopure (R)-heteroarylpyrimidine analogs.

@en

An efficient synthesis of enantiopure

@nl

prefLabel

An efficient synthesis of enantiopure (R)-heteroarylpyrimidine analogs.

@en

An efficient synthesis of enantiopure

@nl

P1476

An efficient synthesis of enantiopure (R)-heteroarylpyrimidine analogs

@en

P2093

Dong-Mei Zhao

http://www.w3.org/2001/XMLSchema#string

Guang-Qiang Xia

http://www.w3.org/2001/XMLSchema#string

Guo-Ming Zhao

http://www.w3.org/2001/XMLSchema#string

Song Li

http://www.w3.org/2001/XMLSchema#string

Xiao-Kui Wang

http://www.w3.org/2001/XMLSchema#string

Xiu-Yan Yang

http://www.w3.org/2001/XMLSchema#string

Zhi-Bing Zheng

http://www.w3.org/2001/XMLSchema#string

P2860

Diels-Alder cycloaddition for fluorophore targeting to specific proteins inside living cells

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

A heteroaryldihydropyrimidine activates and can misdirect hepatitis B virus capsid assembly

Antivirals interacting with hepatitis B virus core protein and core mutations may misdirect capsid assembly in a similar fashion.

A prospective study of the evolution of lamivudine resistance mutations in patients with chronic hepatitis B treated with lamivudine.

Global structural changes in hepatitis B virus capsids induced by the assembly effector HAP1.

Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids.

Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse model.

2-Amino-N-pyrimidin-4-ylacetamides as A2A receptor antagonists: 1. Structure-activity relationships and optimization of heterocyclic substituents.

1,4-Dihydropyridines: Effects of Chirality and Conformation on the Calcium Antagonist and Calcium Agonist Activities

P304

11144-11152

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/MOLECULES180911144

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24029747

http://www.w3.org/2001/XMLSchema#string

P932

6270617

http://www.w3.org/2001/XMLSchema#string